Eco R1 Capital, LLC Fibrogen Inc Call Options Transaction History

Eco R1 Capital, LLC

  • $2.31 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 14, 2020
BUY
$34.58 - $48.06 $829,920 - $1.15 Million
24,000 Added 3.68%
676,500 $29 Million
Q3 2019

Nov 14, 2019
BUY
$36.98 - $48.45 $13.9 Million - $18.2 Million
375,000 Added 135.14%
652,500 $24.1 Million
Q2 2019

Aug 14, 2019
BUY
$35.13 - $55.53 $9.75 Million - $15.4 Million
277,500 New
277,500 $12.5 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email